Advertisement

Potassium Chloride Injection

[24 September 2014]

Products Affected - Description

Potassium chloride for Injection, (Fresenius Kabi, formerly APP)
2 mEq/mL, 30 mEq/15 mL vials, package of 25 (NDC 63323-0965-15) - discontinued
2 mEq/mL, 20 mEq/10 mL vials, package of 25 (NDC 63323-0965-10)
 
Potassium chloride for injection, Baxter 
10 mEq/1000 mL in 5% dextrose (NDC 00338-0681-04) - discontinued
 
Potassium chloride for injection, Hospira
2 mEq/mL, 30 mEq/15 mL vials, package of 25 (NDC 00409-6636-01)
20 mEq/1000 mL in 0.45% sodium chloride (NDC 00409-9257-39)
10 mEq/1000 mL in 5% dextrose and 0.45% sodium chloride (NDC 00409-7993-09)
20 mEq/1000 mL in 5% dextrose and 0.45% sodium chloride (NDC 00409-7902-09)
20 mEq/1000 mL in 5% dextrose and 0.9% sodium chloride (NDC 00409-7107-09)
40 mEq/1000 mL in 0.9% sodium chloride (NDC 00409-7116-09)
20 mEq/1000 mL in lactated ringers and 5% dextrose (NDC 00409-7111-09)

Reason for the Shortage

  • Hospira states the reason for the shortage is manufacturing delays.
  • Fresenius Kabi and Baxter could not provide a reason for the shortage.

Available Products

Potassium chloride for Injection, Fresenius Kabi (formerly APP)
2 mEq/mL, 10 mEq/5 mL vials, package of 25 (NDC 63323-0965-05)
2 mEq/mL, 40 mEq/20 mL vials, package of 25 (NDC 63323-0965-20)
2 mEq/mL, 60 mEq/30 mL vials, package of 25 (NDC 63323-0967-30
 
Potassium chloride for Injection, BBraun
2 mEq/mL, 250 mL bulk package (NDC 00264-1940-20)
 
Potassium chloride for injection, Baxter
10 mEq/50 mL in sterile water (NDC 00338-0705-41)
10 mEq/100 mL in sterile water (NDC 00338-0709-48)
20 mEq/50 mL in sterile water (NDC 00338-0703-41)
20 mEq/100 mL in sterile water (NDC 00338-0705-48)
40 mEq/100 mL in sterile water (NDC 00338-0703-48)
20 mEq/1000 mL in 5% dextrose (NDC 00338-0683-04)
20 mEq/1000 mL in 0.45% sodium chloride (NDC 00338-0704-34)
20 mEq/1000 mL in 0.9% sodium chloride (NDC 00338-0691-04)
40 mEq/1000 mL in 0.9% sodium chloride (NDC 00338-0695-04)
20 mEq/1000 mL in 5% dextrose and 0.2% sodium chloride (NDC 00338-0663-04)
10 mEq/1000 mL in 5% dextrose and 0.45% sodium chloride (NDC 00338-0669-04)
20 mEq/1000 mL in 5% dextrose and 0.45% sodium chloride (NDC 00338-0671-04)
20 mEq/500 mL in 5% dextrose and 0.45% sodium chloride (NDC 00338-0671-03)
30 mEq/1000 mL in 5% dextrose and 0.45% sodium chloride (NDC 00338-0673-04)
40 mEq/1000 mL in 5% dextrose and 0.45% sodium chloride (NDC 00338-0675-04)
20 mEq/1000 mL in 5% dextrose and 0.9% sodium chloride (NDC 00338-0803-04)
40 mEq/1000 mL in 5% dextrose and 0.9% sodium chloride (NDC 00338-0807-04)
20 mEq/500 mL in 5% dextrose and 0.2% sodium chloride (NDC 00338-0663-03)
20 mEq/1000 mL in lactated ringers and dextrose 5% (NDC 00338-0811-04)
 
Potassium chloride for Injection, Hospira
2 mEq/mL, 250 mL bulk package (NDC 00409-1513-02)
2 mEq/mL, 10 mEq/5 mL vials, package of 25 (NDC 00409-6635-01)
2 mEq/mL, 20 mEq/10 mL vials, package of 25 (NDC 00409-6651-06)
2 mEq/mL, 40 mEq/20 mL vials, package of 25 (NDC 00409-6653-05)
10 mEq/50 mL, in sterile water, package of 24 (NDC 00409-7075-14)
10 mEq/100 mL in sterile water, package of 24 (NDC 00409-7074-26)
20 mEq/50 mL, in sterile water, package of 24 (NDC 00409-7077-14)
20 mEq/100 mL, in sterile water, package of 24 (NDC 00409-7075-26)
40 mEq/100 mL, in sterile water, package of 24 (NDC 00409-7077-26)
10 mEq/500 mL in 5% dextrose and 0.225% sodium chloride (NDC 00409-7901-03)
20 mEq/1000 mL in 5% dextrose and 0.225% sodium chloride (NDC 00409-7901-09)
10 mEq/ 500 mL in 5% dextrose and 0.45% sodium chloride (NDC 00409-7902-03)
30 mEq/1000 mL in 5% dextrose and 0.45% sodium chloride (NDC 00409-7903-09)
40 mEq/1000 mL in 5% dextrose and 0.45% sodium chloride (NDC 00409-7904-09)
40 mEq/1000 mL in 5% dextrose and 0.9% sodium chloride (NDC 00409-7109-09)
20 mEq/1000 mL in 5% dextrose (NDC 00409-7905-09)
20 mEq/1000 mL in 0.9% sodium chloride (NDC 00409-7115-09)

Estimated Resupply Dates

  • Fresenius Kabi has potassium chloride 20 mEq/10 mL vials on back order and the company estimates a release date in late-October 2014.
  • Hospira has potassium chloride 30 mEq/15 mL vials on back order and the company cannot estimate a release date. Potassium chloride 20 mEq/1000 mL in lactated ringers and 5% dextrose and potassium chloride 10 mEq/1000 mL 5% dextrose and 0.45% sodium chloride are on back order with an estimated release date in October 2014. Several potassium chloride presentations are available on allocation.

Related Shortages

Updated

September 24, 2014; September 5, 2014; August 6, 2014; July 17, 2014; July 2, 2014; May 29, 2014; May 22, 2014; April 15, 2014; April 1, 2014; March 14, 2014; February 27, 2014; January 22, 2014; December 16, 2013; December 5, 2013; November 8, 2013; October 9, 2013; September 26, 2013; August 29, 2013; August 6, 2013; July 30, 2013; July 3, 2013; June 25, 2013; June 4, 2013; May 28, 2013; April 29, 2013; April 1, 2013; March 8, 2013; February 7, 2013; December 13, 2012; November 7, 2012; October 26, 2012; October 1, 2012; September 12, 2012; August 27, 2012; August 10, 2012; July 26, 2012; July 6, 2012; June 13, 2012; June 1, 2012; May 30, 2012; May 15, 2012; May 2, 2012; April 18, 2012; March 21, 2012; March 12, 2012; February 28, 2012; University of Utah, Drug Information Service. Copyright 2014, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement